PERMIT WP5 hosted its third virtual working session, with a focus on animal models for personalised medicine, on June 22nd. The group consisted of nine experts from various aspects of modelling human disease in animals, including a patient representative. The discussion topics related to evidence-based methods and quality control of animal experiments, with an emphasis on relevance for patients. Accurate reporting is essential, increased transparency and preregistration of animal experiments was advocated. The outcome of this meeting will be discussed further in a dedicated workshop titled “Recommendations for more robust and reproducible preclinical research in personalised medicine” scheduled for Wednesday, September 1st.
@ECRIN_ERIC
Jul 21st
On July 7 the #PERMITproject held its General Assembly. It was an opportunity to reflect on the achievements of the past 6 months, as efforts shift towards drafting recommendations on #personalisedmedicine research.
Learn more: permit-eu.org/article/3rd-pe… https://t.co/MAfW1CcOeF
@EatrisEric
Jul 20th
#CellularModels for #PersonalisedMedicine were the final topic in the #PERMITproject series on #preclinical methods for personalised medicine on 30 June. Read more about the session and outcomes here: permit-eu.org/article/focus-… ECRIN_ERIC https://t.co/DoAx6i9KoE
@ECRIN_ERIC
Jul 16th
The regulatory framework for personalised medicine research can be difficult to navigate. The #PERMITproject gathered over 30 experts to discuss the existing gaps and challenges, and opportunities for recommendations.
permit-eu.org/article/regula… https://t.co/d51JlREWRK
